The most advanced vaccine strategy for pancreas cancer is a combination of low dose cyclophosphamide with GVAX, composed of two irradiated GM-CSF secreting allogeneic pancreas cancer cell lines, followed by CRS-207, a live attenuated Listeria monocytogenes that secretes mesothelin [6]. The gene discussed is CSF2; the disease is pancreatic neoplasm.